The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation
This document is based on consensus among perinatal experts throughout the world and also serves as a guideline for use in clinical practice
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:This practice guideline follows the mission of the World Association of Perinatal Medicine (WAPM) in collaboration with the Perinatal Medicine Foundation (PMF), bringing together groups and individuals throughout the world with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation.
📊
Temel Bulgular & Veri:In fact, this document provides further guidance for healthcare practitioners on the appropriate use of ACS with the aim to increase the timely administration and avoid unnecessary or excessive use.
💡
Sonuç & Katkı:This document is based on consensus among perinatal experts throughout the world and also serves as a guideline for use in clinical practice
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Abstract
This practice guideline follows the mission of the World Association of Perinatal Medicine (WAPM) in collaboration with the Perinatal Medicine Foundation (PMF), bringing together groups and individuals throughout the world with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation. In fact, this document provides further guidance for healthcare practitioners on the appropriate use of ACS with the aim to increase the timely administration and avoid unnecessary or excessive use. Therefore, it is not intended to establish a legal standard of care. This document is based on consensus among perinatal experts throughout the world and also serves as a guideline for use in clinical practice
🔖
Bu Makaleye Atıf Yap
DAGKLİS, T., TSAKIRIDIS, I., VILLALAIN, C., VOLPE, N., ALLEGAERT, K., WELLMANN, S., KUSUDA, S., SERRA, B., LUNA, M. S., HUERTAS, E., AYALA, R., JEKOVA, N., GRUNEBAUM, A., STANOJEVIC, M., ŞEN, C. (2022). The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine Foundation. Perinatal journal (Online), Cilt: 30 - Sayı: 1, 1–11. https://ajindex.com/articles/588294
World Health Organization (WHO 2016). ICD-10: international statistical classification of diseases and related health problems: tenth revision. 5th ed. https://icd.who.int/browse10/ Content/statichtml/ICD10Volume2_en_2016.pdf [Accessed 30 Dec 2021]
Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science 2014;345:760-5. [PubMed] [CrossRef] 3. Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993–2012. JAMA 2015;314: 1039–51. [PubMed] [CrossRef] 4. Dagklis T, Tsakiridis I, Papazisis G, Athanasiadis A. Efficacy and safety of corticosteroids’ administration for pulmonary ›mmaturity in anticipated preterm delivery. Curr Pharm Des 2021;27:3754–61. [PubMed] [CrossRef] 5. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 1972;50:515–25. [PubMed] [CrossRef] 6. Adams TM, Kinzler WL, Chavez MR, Vintzileos AM. The timing of administration of antenatal corticosteroids in women with indicated preterm birth. Am J Obstet Gynecol 2015;212:645 e1–4. [PubMed] [CrossRef] 7. van der Laan S, Meijer OC. Pharmacology of glucocorticoids: beyond receptors. Eur J Pharmacol 2008;585:483–91. [PubMed] [CrossRef] 8. Hillman NH, Kallapur SG, Jobe AH. Physiology of transition from intrauterine to extrauterine life. Clin Perinatol 2012;39: 769–83. [PubMed] [CrossRef] 9. Rubarth LB, Quinn J. Respiratory development and respiratory distress syndrome. Neonatal Netw 2015;34:231–8. [PubMed] [CrossRef] 10. Jobe AH. The amazing premature lung. Am J Perinatol 2019; 36(S02):S1–S3. [PubMed] [CrossRef] 11. Whitsett JA, Matsuzaki Y. Transcriptional regulation of perinatal lung maturation. Pediatr Clin North Am 2006;53:873– 87, viii. [PubMed] [CrossRef] 12. Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am J Obstet Gynecol 1995;173:254–62. [PubMed] [CrossRef] 13. Hogan M, Kuliszewski M, Lee W, Post M. Regulation of phosphatidylcholine synthesis in maturing type II cells: increased mRNA stability of CTP:phosphocholine cytidylyltransferase. Biochem J 1996;314(Pt 3):799–803. [CrossRef] 14. McEvoy C, Schilling D, Peters D, Tillotson C, Spitale P, Wallen L, et al. Respiratory compliance in preter